Moreover, the infiltration numbers of CD8+ and CD4+ cells were also significantly enhanced in the tumours after the BP + aCD47 combination treatment compared to the control (Fig. 6b, c), thus triggering efficacious adaptive antitumour immunity. The gene discussed is CD8A; the disease is neoplasm.